subscribeSubscribe
Marius Publishes Phase 3 KYZATREX® Testosterone Data

Marius Publishes Phase 3 KYZATREX® Testosterone Data
PR NEWSWIRE
11 Apr 2024
Share Share
Marius Pharmaceuticals Expands Access of KYZATREX to Department of VA

Marius Pharmaceuticals Expands Access of KYZATREX to Department of VA
GLOBENEWSWIRE
19 Sep 2023
Share Share
Tolmar Announces Acquisition of JATENZO for the Treatment of Hypogonadism

Tolmar Announces Acquisition of JATENZO for the Treatment of Hypogonadism
PRNEWSWIRE
27 Oct 2022
Share Share
Clarus Therapeutics Holdings,. Announces Plan for Near-Term Sale of JATENZO®

Clarus Therapeutics Holdings,. Announces Plan for Near-Term Sale of JATENZO®
GLOBENEWSWIRE
05 Sep 2022
Share Share
Clarus` fate in limbo as lead drug Jatenzo sputters

Clarus` fate in limbo as lead drug Jatenzo sputters
Fraiser Kansteiner FIERCEPHARMA
20 Aug 2022
Share Share
Marius Pharmaceuticals Receives FDA Approval of KYZATREX

Marius Pharmaceuticals Receives FDA Approval of KYZATREX
GLOBENEWSWIRE
02 Aug 2022
Share Share
Clarus Therapeutics to Present New Data for JATENZO at ENDO 2022

Clarus Therapeutics to Present New Data for JATENZO at ENDO 2022
GLOBENEWSWIRE
09 Jun 2022
Share Share
Clarus Tx Announces Notice of Allowance for Patent Claims Covering JATENZO

Clarus Tx Announces Notice of Allowance for Patent Claims Covering JATENZO
GLOBENEWSWIRE
28 Apr 2022
Share Share
Clarus to Present New Data for JATENZO at Androgen Society 4th Annual Meeting

Clarus to Present New Data for JATENZO at Androgen Society 4th Annual Meeting
GLOBENEWSWIRE
19 Apr 2022
Share Share
Clarus Announces Strategic Partnerships for JATENZO with Vault Health & AssistRx

Clarus Announces Strategic Partnerships for JATENZO with Vault Health & AssistRx
GLOBENEWSWIRE
24 Feb 2022
Share Share